Cargando…

Exposing drug industry funding of UK patient organisations

Drug company payment disclosures have limited transparency, but Piotr Ozieranski and colleagues find that they are increasing in value and are targeted at select patient organisations

Detalles Bibliográficos
Autores principales:	Ozieranski, Piotr, Rickard, Emily, Mulinari,, Shai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2019
Materias:	Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529850/ https://www.ncbi.nlm.nih.gov/pubmed/31122928 http://dx.doi.org/10.1136/bmj.l1806

Ejemplares similares

Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs
por: Mulinari, Shai, et al.
Publicado: (2020)

Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012–2016)
por: Ozieranski, Piotr, et al.
Publicado: (2020)

Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise?
por: Pashley, Dylan, et al.
Publicado: (2022)

Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015
por: Ozieranski, Piotr, et al.
Publicado: (2019)

Exposing drug industry funding of UK patient organisations
Publicado: (2019)

International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency
por: Ozieranski, Piotr, et al.
Publicado: (2023)

Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK database, 2015 and 2016 cohorts
por: Mulinari, Shai, et al.
Publicado: (2018)

Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database
por: Ozieranski, Piotr, et al.
Publicado: (2023)

Accessibility and quality of drug company disclosures of payments to healthcare professionals and organisations in 37 countries: a European policy review
por: Ozieranski, Piotr, et al.
Publicado: (2021)

A hidden web of policy influence: The pharmaceutical industry’s engagement with UK’s All-Party Parliamentary Groups
por: Rickard, Emily, et al.
Publicado: (2021)

Conflicted and confused? Health harming industries and research funding in leading UK universities
por: Collin, Jeff, et al.
Publicado: (2021)

Drug company payments to General Practices in England: Cross-sectional and social network analysis
por: Saghy, Eszter, et al.
Publicado: (2021)

Tip of the Iceberg? Country- and Company-Level Analysis of Drug Company Payments for Research and Development in Europe
por: Ozieranski, Piotr, et al.
Publicado: (2022)

Industry funding of patient organisations in the UK: a retrospective study of commercial determinants, funding concentration and disease prevalence
por: Gentilini, Arianna, et al.
Publicado: (2023)

Comparing pharmaceutical company payments in the four UK countries: a cross-sectional and social network analysis
por: Rickard, Emily, et al.
Publicado: (2023)

How organisations contribute to improving the quality of healthcare
por: Fulop, Naomi J, et al.
Publicado: (2019)

Understanding organisational culture for healthcare quality improvement
por: Mannion, Russell, et al.
Publicado: (2018)

An early analysis of the World Bank’s Pandemic Fund: a new fund for pandemic prevention, preparedness and response
por: Boyce, Matthew R, et al.
Publicado: (2023)

Industry funding of patient and health consumer organisations: systematic review with meta-analysis
por: Fabbri, Alice, et al.
Publicado: (2020)

Availability and funding of clinical genomic sequencing globally
por: Phillips, Kathryn A, et al.
Publicado: (2021)

Grassroots organisations and the sustainable development goals: no one left behind?
por: Flores, Walter, et al.
Publicado: (2019)

Towards universal health coverage: governance and organisational change in ministries of health
por: Berman, Peter, et al.
Publicado: (2019)

The Pandemic Treaty, the Pandemic Fund, and the Global Commons: our scepticism
por: Evaborhene, Nelson Aghogho, et al.
Publicado: (2023)

Associations, unions and everything in between: contextualising the role of representative health worker organisations in policy
por: Sriram, Veena, et al.
Publicado: (2023)

Misleading Advertising for Antidepressants in Sweden: A Failure of Pharmaceutical Industry Self-Regulation
por: Zetterqvist, Anna V., et al.
Publicado: (2013)

Earmarking for global health: benefits and perils of the World Bank’s trust fund model
por: Winters, Janelle, et al.
Publicado: (2017)

Organisation of primary health care in the Asia-Pacific region: developing a prioritised research agenda
por: Palagyi, Anna, et al.
Publicado: (2019)

Organising knowledge to prevent global health crises: a comparative analysis of pandemic preparedness indicators
por: Kentikelenis, Alexander, et al.
Publicado: (2021)

Complaints, Complainants, and Rulings Regarding Drug Promotion in the United Kingdom and Sweden 2004–2012: A Quantitative and Qualitative Study of Pharmaceutical Industry Self-Regulation
por: Zetterqvist, Anna V., et al.
Publicado: (2015)

Using economic evidence to support policy decisions to fund interventions for non-communicable diseases
por: Bertram, Melanie, et al.
Publicado: (2019)

The impact of UN high-level meetings on non-communicable disease funding and policy implementation
por: Akselrod, Svetlana, et al.
Publicado: (2023)

Decision-making approaches used by UK and international health funding organisations for allocating research funds: A survey of current practice
por: Meadmore, Katie, et al.
Publicado: (2020)

Unmasking the vulnerabilities of uninfected children exposed to HIV
por: Ramokolo, Vundli, et al.
Publicado: (2019)

The role of network bridging organisations in compensation payments for agri-environmental services under the EU Common Agricultural Policy
por: Dedeurwaerdere, Tom, et al.
Publicado: (2015)

Innovative financing to fund surgical systems and expand surgical care in low-income and middle-income countries
por: Reddy, Ché L, et al.
Publicado: (2020)

Tackling racism in UK health research
por: Powell, Richard Antony, et al.
Publicado: (2022)

Psychopathology in children exposed to trauma: detection and intervention needed to reduce downstream burden
por: Danese, Andrea, et al.
Publicado: (2020)

Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of ‘deep’ product reviews
por: Mulinari, Shai, et al.
Publicado: (2017)

Can we import improvements from industry to healthcare?
por: Macrae, Carl, et al.
Publicado: (2019)

Illicit trade, tobacco industry-funded studies and policy influence in the EU and UK
por: Fooks, Gary Jonas, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rujse78rtksss7rnngutv2u3gq